chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt reports L sided numbness/tingling, warmth and feelings of facial paralysis 40 minutes after receiving the 1st vaccine. Pt was driving so was not able to look in the mirror to see if facial paralysis was true. Resolved after 10 minutes.
Terrible stomach discomfort; The stomach discomfort was upgraded from discomfort to pain; Diarrhea; Fever; Vomiting; A lot of muscle aches/body aches; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Terrible stomach discomfort), ABDOMINAL PAIN UPPER (The stomach discomfort was upgraded from discomfort to pain), DIARRHOEA (Diarrhea), PYREXIA (Fever) and VOMITING (Vomiting) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053E21A, 029K20A and 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ALOPURINOL, ASPIRIN [ACETYLSALICYLIC ACID], OMEPRAZOLE, AMLODIPINE and VALSARTAN for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (Terrible stomach discomfort), ABDOMINAL PAIN UPPER (The stomach discomfort was upgraded from discomfort to pain), DIARRHOEA (Diarrhea), PYREXIA (Fever), VOMITING (Vomiting), MYALGIA (A lot of muscle aches/body aches) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and ONDANSETRON ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, ABDOMINAL DISCOMFORT (Terrible stomach discomfort), ABDOMINAL PAIN UPPER (The stomach discomfort was upgraded from discomfort to pain), DIARRHOEA (Diarrhea), PYREXIA (Fever), VOMITING (Vomiting), MYALGIA (A lot of muscle aches/body aches) and NAUSEA (Nausea) outcome was unknown.            treatment information was reported Tylenol, ondansetron 8 mg Lab data included : Two stomach surgeries in the past: colon surgery and  recent one on February 2020 that was a gallbladder surgery. Patient reported scar tissue which bothered him from time to time.   This case was linked to MOD-2021-299983 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Sep-2021: Follow up received on 01-SEP-2021. No new information
A red splotch first appeared a couple days after the injection. It was located right beneath the injection. It continued to grow with a slight itchiness.  It went away after a few days. It reappeared on Feb. 23 with more redness and larger, and it itches more.  I applied topical Benadryl but it doesn't seem to help the itching. The itching is annoying. There is no pain with slight swelling.
Post vax, pt began running a low-grade temperature. Mother gave Tylenol after immunizations. Pt ran a fever then during the day of 6/7/01 even using Tylenol alternating with Motrin. At 17:30 on 6/7/01 or 24 hours, post vax, pt spiked a fever of 105F. Family physician contacted. Continued Tylenol alternating with Motrin and cool baths. Child cried for 24 hours. This date of 6/8/01, still has a low-grade temperature but no further crying.
Three months later, I had the same reaction:  I woke up with one day of sore throat, then chills for three days; chest congestion; sinus congestion; I was so cold; including chills; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 22Mar2021 12:00 (Lot number: EN6207) at the age of 63 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; VITAMIN D NOS. Vaccination history included: Bnt162b2 (Dose 1, Lot number EN6201, lot unknown False, administration date 01Mar2021, administration time 12:00 PM, vaccine location Right arm), administration date: 01Mar2021, when the patient was 63 years old, for COVID-19 Immunization. The following information was reported: CHILLS (non-serious) with onset 22Mar2021, outcome "recovered" (2021), described as "including chills"; OROPHARYNGEAL PAIN (non-serious) with onset 30Jun2021 08:00, outcome "recovered" (2021), described as "Three months later, I had the same reaction:  I woke up with one day of sore throat, then chills for three days"; RESPIRATORY TRACT CONGESTION (non-serious) with onset 30Jun2021 08:00, outcome "recovered" (2021), described as "chest congestion"; SINUS CONGESTION (non-serious) with onset 30Jun2021 08:00, outcome "recovered" (2021), described as "sinus congestion"; FEELING COLD (non-serious) with onset 30Jun2021 08:00, outcome "recovered" (2021), described as "I was so cold". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of chills, oropharyngeal pain, respiratory tract congestion, sinus congestion, feeling cold.  Additional Information: No other vaccine in four weeks. Took lisinopril 10mg 1xday, vit d 2000 iu, 1xday in two weeks. The patient had a typical reaction to the second injection on 22Mar2021, including chills, but Three months later, had the same reaction. She woke up with one day of sore throat, then chills for three days, followed by chest congestion and sinus congestion. Because the symptoms so closely resembled the side effects of my second Pfizer vaccine injection, she got a Covid PCR test (negative) at pharmacy. The body temperature for three days hovered around 89.7-90.5. I was so cold. It was nothing she have experienced previously in her long life. She self isolated for ten days, and am now back to normal. No covid prior vaccination. Covid test post vaccination {covid test type post vaccination Nasal Swab, covid test name post vaccination pcr, covid test date 03Jul2021, covid test result Negative}. No known allergies.                                 No follow-up attempts are possible. No further information is expected.
12 month old toddler developed characteristic prodomal fever for 2 days prior to rash on face and behind ears which the progressed to involve body c/w measles.  Toddler received MMR vaccine 13 days prior to evaluation on 5/1/08 which is about 10-11 days before onset of fever.
Lethargic - difficult to arouse - poor feedings; Given APAP- no medical treatment; no fever, no fussiness;
Patient complained of bilaterial face numbness after vaccine. 50 mg of Benadryl given.
Stuffy nose, sinus ache, body aches, cold sweats Sep 29th through Oct 2.
Case number PHEH2013US013679 is an initial spontaneous report received from a nurse on 20 Jun 2013. This case refers to a 1-year-old infant of unspecified gender. The nurser stated that the MMR vaccine (other manufacturer, batch number: not reported) was reconstitute with the MenCYW component of MENVEO (batch number: not reported) and was administered to this patient on an unspecified date. No adverse event was reported at the time of this report. No other information was available.
around 6 PM I started vomiting for what seemed like 2 hours or so, I needed an abmbulance to get me becuase I could not walk or put my shoes on or answer the door. I was losing consiousness. Dry mouth.
17 y/o presented for Moderna COVID-19 vaccine accompanied by mother, whom signed consent for vaccination. Patient was monitored post injection x 15 minutes with no side effects.  Mother instructed on possible side effects to monitor and report.
chills; rash mild below injection site; slight burning feeling mild below injection site; itchy mild below injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy mild below injection site), VACCINATION SITE RASH (rash mild below injection site), VACCINATION SITE PAIN (slight burning feeling mild below injection site) and CHILLS (chills) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy mild below injection site) and VACCINATION SITE PAIN (slight burning feeling mild below injection site). On 27-Mar-2021, the patient experienced VACCINATION SITE RASH (rash mild below injection site). On an unknown date, the patient experienced CHILLS (chills). At the time of the report, VACCINATION SITE PRURITUS (itchy mild below injection site), VACCINATION SITE RASH (rash mild below injection site), VACCINATION SITE PAIN (slight burning feeling mild below injection site) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded
developed covid symptoms ,sore muscles,cold symptoms,runny nose, a bit of coughing; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (developed covid symptoms ,sore muscles,cold symptoms,runny nose, a bit of coughing) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Patient had no relevant medical history/conditions, allergy, concomitant diseases and risk factor.     On 20-Dec-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jan-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (developed covid symptoms ,sore muscles,cold symptoms,runny nose, a bit of coughing). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) for Cold symptoms, at an unspecified dose and frequency. At the time of the report, COVID-19 (developed covid symptoms ,sore muscles,cold symptoms,runny nose, a bit of coughing) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Jan-2023, SARS-CoV-2 test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  The patient had not received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Patient reported that she received the first dose of Moderna Monovalent Primary series on 20Dec2022, and developed covid symptoms the night of 01jan2023.  For 3 days patient experienced sore muscles, cold symptoms such as runny nose, a bit of coughing, and had no fever.   Patient would like to know when she is eligible to receive 2nd primary dose because her symptoms had topped but continued to show positive on Antigen home test.  The patient did not seek medical attention and only took cold medicine for cold symptoms and asking how to make positive test go away faster.   Patient did not know the LOT number.   Reporter did not allow further contact
48 hours after receiving the 2nd dose of varicella vaccine the client called complaining of low grade fever, both arms and one leg felt  "Funny and tingle" and felt very tired and sleepy.  Refused to see a physician for evaluation.  Daily phone contact with client revealed she improved and symptoms completely resolved with no complications.  Never would see a physician.
Patient started feeling tingling and numbness in the feet and it progressed over the next several weeks and months to numbness in the legs and groin area. Patient saw chiropractors, acupuncturists, and neurologists as symptoms progressed and was diagnosed by a neurologist as Guillan Barre Syndrome (GBS). Patient at one point developed foamy jucous in the mouth.
This spontaneous report as received from a nurse refers to a 13 year old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 19-SEP-2017, the patient was vaccinated with improperly stored GARDASIL 9 (dosing details were not reported) (lot # N019923, expiry date: 28-APR-2019) for prophylaxis. No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA000054: US-009507513-1709USA007012: US-009507513-1709USA007011: US-009507513-1709USA007014.
Adacel was administered after being improperly stored with no reported adverse event; Initial information received on 13-Mar-2023 regarding an unsolicited valid non-serious case received from other health professional.  This case involves an unknown age and unknown gender patient to whom diphtheria-2/tetanus/5 AC pertussis vaccine [Adacel] was administered after being improperly stored with no reported adverse event.  The patient's past medical treatment(s), vaccination(s), concomitant medication and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.    On an unknown date, the patient received suspect diphtheria-2/tetanus/5 AC pertussis vaccine Suspension for injection at an unknown dose total (lot number, expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination (immunisation).  On an unknown date, adacel was administered after being improperly stored with no reported adverse event (poor quality product administered) (same day latency).  Action taken: Not applicable.  Outcome: Unknown.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Systemic: Fainting / Unresponsive-Severe, Systemic: Seizure-Mild, Systemic: Shakiness-Mild, Systemic: Tachycardia-Medium.
Patient with history of COVID vaccines who admitted to hospital with COVID detected PCR.  Provider d/c note:  "80-year-old female with a past medical history of COPD, HLD, hypothyroidism, and recent hospitalization for hypercalcemia presenting again for hypercalcemia recurrence seen on outpatient labs in addition to acute metabolic encephalopathy.  Her ionized calcium was found to be 1.87. She was administered aggressive IV fluids, calcitonin, and zoledronic acid.  Patient had progressive improvement hypercalcemia with these measures. Given its recurrence, there was concern for underlying malignancy, for which the patient underwent bone marrow biopsy on 1/25/23 with Interventional Radiology. The patient tolerated the procedure well without complication. Prior to discharge, screening for COVID with rapid PCR test was positive, however the patient has been asymptomatic.  She demonstrate clinical improvement in addition to having stabilized corrected serum calcium after discontinuation of IV fluids.  She also had resolution of her presenting acute metabolic encephalopathy. She was discharged in stable condition. "
Chills after the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills after the 1st dose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     The medical history was not provided by the reported.  Concomitant products included ATENOLOL and LISINOPRIL for Blood pressure, SIMVASTATIN for Cholesterol, ACETYLSALICYLIC ACID (ASPIRIN), LEVOTHYROXINE SODIUM (SYNTHROID), OMEPRAZOLE and VITAMIN D NOS for an unknown indication.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced CHILLS (Chills after the 1st dose). On 27-Apr-2021, CHILLS (Chills after the 1st dose) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.        No information regarding treatment was provided.
Pt stated that she had flu vaccine around 10:30am. Patient returned to clinic at 1:15pm and complained of SOB, wheezing, hoarsness. Pt has history of asthma. Pt took asthma medication prior to returning to clinic. Pt decided to call her physician. Pt returned to clinic for the 3rd time at 2:15PM and stated that her doctor advised her to take Benadryl. Benadryl 100mg was given by PHN. 15 minutes after receiving Benadryl patient stated feeling much better.
1st dose - fatigue, SOB, chest pain, nausea -  2nd dose - flu like symptoms for 36 hours - fever over 101, chills,  headache
14JUN95 pt was found to be not breathing by the mother, rushed to local hosp by paramedics & found to be dead on arrival
DTaP given 05/15/2002. Signs of redness 05/16/2003. Examined area 05/17/2003, larger 8 x 8cm indurated, warm, non tender, no fever. Rx Keflex.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient. A 12-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 26Aug2021 16:30 (Lot number: FD8448) at the age of 12 years as dose 1, single for Covid-19 immunization. Relevant medical history included: "Cancer" (unspecified if ongoing); "UTI" (unspecified if ongoing). Concomitant medication(s) included: OMEPRAZOL; SULFAMETHOXAZOLE AND TRIMETHOPRIM; KOSELUGO; VIT. D [COLECALCIFEROL]. The following information was reported: DYSPNOEA (non-serious) with onset 27Aug2021 06:15, outcome "recovering", described as "Difficulty breathing"; INJECTION SITE PAIN (non-serious) with onset 27Aug2021 06:15, outcome "recovering", described as "pain at injection site"; FATIGUE (non-serious) with onset 27Aug2021 06:15, outcome "recovering", described as "fatigue pain at the injection site/tiredness"; HEADACHE (non-serious) with onset 27Aug2021 06:15, outcome "recovering", described as "headache"; MYALGIA (non-serious) with onset 27Aug2021 06:15, outcome "recovering", described as "muscle pain"; ARTHRALGIA (non-serious) with onset 27Aug2021 06:15, outcome "recovering", described as "joint pain"; FEELING ABNORMAL (non-serious) with onset 27Aug2021 06:15, outcome "recovering", described as "feeling bad"; PAIN IN EXTREMITY (non-serious) with onset 27Aug2021 06:15, outcome "recovering", described as "arm pain". Therapeutic measures were not taken as a result of dyspnoea, injection site pain, fatigue, headache, myalgia, arthralgia, feeling abnormal, pain in extremity. Additional information: The patient did not receive any other vaccine in four weeks prior to the COVID vaccine. The patient was neither diagnosed with Covid-19 prior vaccination, nor been tested for Covid-19 post vaccination. No known allergies. No follow-up attempts are possible. No further information is expected.
Weak tender muscles in both arms and legs starting after injection and she had difficulty lifting injected arm above head.  She went to her family doctor and received several blood tests and MD started her on an Antibiotic.  Patient said weakness in non- injection arm is starting to go away in last part of December.
swollen ankles; vasculitis; was not getting any better; she even had more bumps (not a rash, knuckles and bumps under skin),some of these bumps were on blood vessels; ache; red lumps under the skin; chills; fever; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (ache), ERYTHEMA (red lumps under the skin), NODULE (she even had more bumps (not a rash, knuckles and bumps under skin),some of these bumps were on blood vessels), JOINT SWELLING (swollen ankles) and VASCULITIS (vasculitis) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043L20A and 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by reporter.  Concomitant products included LOSARTAN POTASSIUM, METOPROLOL, ATORVASTATIN and HYDROCHLOROTHIAZIDE for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Feb-2021, the patient experienced MYALGIA (arm was sore). On 07-Sep-2021, the patient experienced PAIN (ache), ERYTHEMA (red lumps under the skin), CHILLS (chills) and PYREXIA (fever). On 14-Sep-2021, the patient experienced NODULE (she even had more bumps (not a rash, knuckles and bumps under skin),some of these bumps were on blood vessels) and MALAISE (was not getting any better). On an unknown date, the patient experienced JOINT SWELLING (swollen ankles) and VASCULITIS (vasculitis). On 02-Feb-2021, MYALGIA (arm was sore) outcome was unknown. At the time of the report, PAIN (ache), ERYTHEMA (red lumps under the skin), NODULE (she even had more bumps (not a rash, knuckles and bumps under skin),some of these bumps were on blood vessels), JOINT SWELLING (swollen ankles), VASCULITIS (vasculitis), MALAISE (was not getting any better), CHILLS (chills) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Sep-2021, C-reactive protein: 137 (High) C-reactive protein increased.. On 14-Sep-2021, Red blood cell sedimentation rate: 78 (High) Red blood cell sedimentation rate increased.. On an unknown date, SARS-CoV-2 test negative: negative (Negative) Negative.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication reported.   This case was linked to MOD-2021-322335.
Systemic: Hypertension-Medium, Systemic: Tachycardia-Medium